Mimedx Group Stock Performance

MDXG Stock  USD 5.16  0.04  0.78%   
The company secures a Beta (Market Risk) of 0.92, which conveys possible diversification benefits within a given portfolio. MiMedx returns are very sensitive to returns on the market. As the market goes up or down, MiMedx is expected to follow. At this point, MiMedx Group has a negative expected return of -0.35%. Please make sure to verify MiMedx's jensen alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if MiMedx Group performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days MiMedx Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more

Actual Historical Performance (%)

One Day Return
0.78
Five Day Return
1.18
Year To Date Return
(20.37)
Ten Year Return
(34.10)
All Time Return
11.21
Last Split Date
2008-04-02
1
MiMedx Secures Exclusive Deal for U.S. Distribution of Re - GuruFocus
12/22/2025
2
Investors Interested In MiMedx Group, Inc.s Earnings
01/09/2026
3
MiMedx Group Hits New 12-Month Low - Heres What Happened - MarketBeat
01/14/2026
4
Acquisition by Behrens M Kathleen of 28609 shares of MiMedx at 6.47 subject to Rule 16b-3
01/15/2026
5
MiMedx Group Given New 10.00 Price Target at Lake Street Capital - MarketBeat
01/20/2026
6
Lake Street Capital Cuts MiMedx Group Price Target to 10.00
01/23/2026
7
252,000 Shares in MiMedx Group, Inc MDXG Purchased by Hussman Strategic Advisors Inc.
01/28/2026
8
MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical Wound Products
02/04/2026
9
Insider Trading
02/09/2026
10
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25
02/17/2026
Begin Period Cash Flow82 M
Total Cashflows From Investing Activities-9.6 M

MiMedx Relative Risk vs. Return Landscape

If you would invest  648.00  in MiMedx Group on November 19, 2025 and sell it today you would lose (132.00) from holding MiMedx Group or give up 20.37% of portfolio value over 90 days. MiMedx Group is currently does not generate positive expected returns and assumes 2.0586% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of stocks are less volatile than MiMedx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days MiMedx is expected to under-perform the market. In addition to that, the company is 2.73 times more volatile than its market benchmark. It trades about -0.17 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.16 per unit of volatility.

MiMedx Target Price Odds to finish over Current Price

The tendency of MiMedx Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 5.16 90 days 5.16 
about 91.07
Based on a normal probability distribution, the odds of MiMedx to move above the current price in 90 days from now is about 91.07 (This MiMedx Group probability density function shows the probability of MiMedx Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days MiMedx has a beta of 0.92. This indicates MiMedx Group market returns are reactive to returns on the market. As the market goes up or down, MiMedx is expected to follow. Additionally MiMedx Group has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   MiMedx Price Density   
       Price  

Predictive Modules for MiMedx

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MiMedx Group. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MiMedx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
2.975.047.11
Details
Intrinsic
Valuation
LowRealHigh
4.316.388.45
Details
5 Analysts
Consensus
LowTargetHigh
8.749.6010.66
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.030.030.03
Details

MiMedx Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. MiMedx is not an exception. The market had few large corrections towards the MiMedx's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MiMedx Group, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MiMedx within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.6
β
Beta against Dow Jones0.92
σ
Overall volatility
0.84
Ir
Information ratio -0.28

MiMedx Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MiMedx for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MiMedx Group can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
MiMedx Group generated a negative expected return over the last 90 days
About 74.0% of the company shares are owned by institutional investors
Latest headline from globenewswire.com: MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25

MiMedx Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MiMedx Stock often depends not only on the future outlook of the current and potential MiMedx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MiMedx's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding149 M
Cash And Short Term Investments104.4 M

MiMedx Fundamentals Growth

MiMedx Stock prices reflect investors' perceptions of the future prospects and financial health of MiMedx, and MiMedx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MiMedx Stock performance.

About MiMedx Performance

By analyzing MiMedx's fundamental ratios, stakeholders can gain valuable insights into MiMedx's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MiMedx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MiMedx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 130.18  100.02 
Return On Tangible Assets 0.16  0.17 
Return On Capital Employed 0.24  0.25 
Return On Assets 0.14  0.15 
Return On Equity 0.20  0.21 

Things to note about MiMedx Group performance evaluation

Checking the ongoing alerts about MiMedx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MiMedx Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
MiMedx Group generated a negative expected return over the last 90 days
About 74.0% of the company shares are owned by institutional investors
Latest headline from globenewswire.com: MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25
Evaluating MiMedx's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate MiMedx's stock performance include:
  • Analyzing MiMedx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MiMedx's stock is overvalued or undervalued compared to its peers.
  • Examining MiMedx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating MiMedx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MiMedx's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of MiMedx's stock. These opinions can provide insight into MiMedx's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating MiMedx's stock performance is not an exact science, and many factors can impact MiMedx's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for MiMedx Stock analysis

When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
CEOs Directory
Screen CEOs from public companies around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets